US health officials reevaluate $590 million bird flu contract with Moderna Inc.

US health officials are reevaluating a $590 million contract for bird flu shots awarded to Moderna Inc. in the final days of the Biden administration. This review is part of a broader examination of spending on messenger RNA-based vaccines, including Moderna's Covid vaccine.